(GLPG) Galapagos - Performance 15.8% in 12m
GLPG performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-75.70%
#117 in Peer-Group
Rel. Strength
56.82%
#3330 in Stock-Universe
Total Return 12m
15.83%
#59 in Peer-Group
Total Return 5y
-85.77%
#101 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 167 |
| High / Low | USD |
|---|---|
| 52 Week High | 31.05 USD |
| 52 Week Low | 22.69 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 78.11 |
| Buy/Sell Signal +-5 | 1.68 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: GLPG (15.8%) vs XBI (-6.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.94% | 73.2% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.16% | -5.32% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.99% | -0.49% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.6% | 32.8% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.29% | -6.6% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
17.1% | 57.4% | -4.19% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-3.2% | 58.3% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
5.64% | 38.5% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: GLPG vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GLPG
| Total Return (including Dividends) | GLPG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.66% | 3.53% | 5.22% |
| 3 Months | 19.58% | 9.10% | 16.86% |
| 12 Months | 15.83% | -6.17% | 14.81% |
| 5 Years | -85.77% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | GLPG | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -14% | 4.4% | 81% |
| 3 Months | 76.6% | 78.8% | 96.9% |
| 12 Months | -12.5% | -85.8% | 44.9% |
| 5 Years | -96.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th40.50 | -2.77% | -4.33% |
| 3 Month | %th62.00 | 9.61% | 2.32% |
| 12 Month | %th71.00 | 23.44% | 0.89% |
| 5 Years | %th48.00 | -81.22% | -93.28% |
FAQs
Does Galapagos (GLPG) outperform the market?
Yes,
over the last 12 months GLPG made 15.83%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.17%.
Over the last 3 months GLPG made 19.58%, while XBI made 9.10%.
Performance Comparison GLPG vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
GLPG vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.5% | -4.6% | -4.8% | 1% |
| US NASDAQ 100 | QQQ | 0.9% | -4.9% | -6.1% | 2% |
| German DAX 40 | DAX | 1.5% | 1.3% | -18.3% | -14% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.2% | -3.6% | -7.7% | -3% |
| Hongkong Hang Seng | HSI | 1.5% | -5.7% | -23.2% | -20% |
| India NIFTY 50 | INDA | 2.6% | -2.7% | -3.1% | 16% |
| Brasil Bovespa | EWZ | -1.5% | -7.6% | -31.6% | 4% |
GLPG vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.2% | -5.9% | -9.5% | -11% |
| Consumer Discretionary | XLY | -0.2% | -2.2% | 3% | -3% |
| Consumer Staples | XLP | 0.2% | 0.7% | -4.8% | 6% |
| Energy | XLE | 1.2% | -4.3% | 0.4% | 18% |
| Financial | XLF | 0% | -3.8% | -8.8% | -14% |
| Health Care | XLV | 1.8% | -1.7% | 3.1% | 20% |
| Industrial | XLI | -0.1% | -3.6% | -11.8% | -9% |
| Materials | XLB | -1.4% | -4% | -9.5% | 10% |
| Real Estate | XLRE | 0.7% | -0.6% | -2.5% | 3% |
| Technology | XLK | 0.4% | -8.2% | -7.9% | 4% |
| Utilities | XLU | 1.9% | 0.7% | -6.2% | -7% |
| Aerospace & Defense | XAR | 1.8% | -7% | -22% | -33% |
| Biotech | XBI | 0.9% | -2.9% | 9.2% | 22% |
| Homebuilder | XHB | -2.4% | -7.9% | 3% | 11% |
| Retail | XRT | -2.5% | -3.6% | -0.3% | 5% |
GLPG vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 0.5% | -6.92% | 4.94% | 23% |
| Natural Gas | UNG | 5.3% | 10.7% | 3.6% | 23% |
| Gold | GLD | 2.6% | 1.2% | -24.7% | -25% |
| Silver | SLV | 2.2% | -5.9% | -22.8% | -5% |
| Copper | CPER | 2.1% | -4.3% | -23.5% | 2% |
GLPG vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.5% | -2% | -0.4% | 17% |
| iShares High Yield Corp. Bond | HYG | 2.3% | -1.1% | -3.3% | 5% |